In clinic, tamoxifen, which competitively combine with estrogen receptor, can not be concurrently used with chemotherapy for breast cancer patients, as the cancer growth inhibition by tamoxifen makes tumor cells insensitive to chemotherapy. The gene discussed is ESR1; the disease is breast carcinoma.